- Filed
- May 9, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · May 9, 2024 | 30.01M sh |
| Cash And Equivalents | Q3 2024 · Mar 31, 2024 | $1.88M |
| Stockholders Equity | Q3 2024 · Mar 31, 2024 | $398.02K |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | −$541.96K |
| Current Liabilities | Q3 2024 · Mar 31, 2024 | $2.12M |
| Current Liabilities | Q3 2024 · Jun 30, 2023 | $2.05M |
| Total Liabilities | Q3 2024 · Mar 31, 2024 | $2.12M |
| Total Liabilities | Q3 2024 · Jun 30, 2023 | $2.05M |
| Current Assets | Q3 2024 · Mar 31, 2024 | $2.22M |
| Current Assets | Q3 2024 · Jun 30, 2023 | $1.31M |
| Total Assets | Q3 2024 · Mar 31, 2024 | $2.54M |
| Total Assets | Q3 2024 · Jun 30, 2023 | $1.48M |
| Shares Diluted restated | Q3 2024 · Mar 31, 2023 | 30M sh |
| Shares Diluted restated | Q3 2024 · Mar 31, 2023 | 30M sh |
| Capex | Q3 2024 · Mar 31, 2023 | $69.58K |
| Operating Cash Flow | Q3 2024 · Mar 31, 2023 | $507.94K |
| Eps Diluted restated | Q3 2024 · Mar 31, 2023 | −$0.01 |
| Eps Diluted restated | Q3 2024 · Mar 31, 2023 | −$0.03 |
| Eps Basic restated | Q3 2024 · Mar 31, 2023 | −$0.01 |
| Eps Basic restated | Q3 2024 · Mar 31, 2023 | −$0.03 |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $634.14K |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $1.42M |
| Net Income restated | Q3 2024 · Mar 31, 2023 | −$430.81K |
| Net Income restated | Q3 2024 · Mar 31, 2023 | −$868.38K |
| Operating Income | Q3 2024 · Mar 31, 2023 | −$472.52K |
| Operating Income | Q3 2024 · Mar 31, 2023 | −$964.64K |
| Gross Profit | Q3 2024 · Mar 31, 2023 | $161.62K |
| Gross Profit | Q3 2024 · Mar 31, 2023 | $460.12K |
| Cost Of Revenue | Q3 2024 · Mar 31, 2023 | $118.52K |
| Cost Of Revenue | Q3 2024 · Mar 31, 2023 | $299.78K |
| Revenue | Q3 2024 · Mar 31, 2023 | $280.14K |
| Revenue | Q3 2024 · Mar 31, 2023 | $759.9K |